08:00 , Nov 5, 2015 |  BC Innovations  |  Distillery Techniques

Techniques: Chemokine CC motif ligand 20 (CCL20; MIP3A) and five other loci as markers for primary biliary cirrhosis (PBC)

BiomarkersCCL20Chemokine CC motif ligand 20MIP3AUniversity of Toronto...
07:00 , Jul 31, 2014 |  BC Innovations  |  Cover Story

Fresh air for COPD

An undisclosed company has picked up an integrin-targeting antibody from the University of California, San Francisco that could address the underlying pathology in chronic obstructive pulmonary disease by improving airway remodeling via suppressing transforming growth...
07:00 , Jun 19, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Asthma Chemokine CC motif ligand 20 (CCL20; MIP3A) Mouse studies suggest the heparan sulfate-binding monosaccharide 2,4-O-disulfated iduronic...
07:00 , Aug 11, 2011 |  BC Innovations  |  Targets & Mechanisms

Gutsy call on Th17 cells

Researchers at the Yale School of Medicine have shown that the small intestine regulates proinflammatory T helper type 17 cells via two mechanisms, including one that leads to an immunosuppressive, regulatory phenotype.1 The findings could...
07:00 , Aug 4, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune; multiple sclerosis (MS) CD3; CC chemokine receptor 6 (CCR6; CD196); chemokine CC motif ligand 20...
07:00 , Oct 29, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer T helper...
07:00 , Apr 16, 2009 |  BC Innovations  |  Targets & Mechanisms

Toll gate against allergic asthma

Marketed treatments for allergic asthma, including corticosteroids and adrenergic receptor b2 agonists, have focused on intervening downstream from the initial inhalation of an allergen. Now, a team of Belgian and American researchers has proposed treating...
07:00 , Mar 12, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease ...